HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes

References

1. Azuma T., Otsuki T., Kuzushima K., Froelich C., Fujita S., Yasukawa M. 2004; Myeloma cells are highly sensitive to granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes. Clin Cancer Res 10:7402–7412 [CrossRef]
   [Google Scholar]
2. Balaji K. N., Schaschke N., Machleidt W., Catalfamo M., Henkart P. A. 2002; Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. J Exp Med 196:493–503 [CrossRef]
   [Google Scholar]
3. Basbous J., Arpin C., Gaudray G., Piechaczyk M., Devaux C., Mesnard J. M. 2003; The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J Biol Chem 278:43620–43627 [CrossRef]
   [Google Scholar]
4. Bird C. H., Sutton V. R., Sun J., Hirst C. E., Novak A., Kumar S., Trapani J. A., Bird P. I. 1998; Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol Cell Biol 18:6387–6398
   [Google Scholar]
5. Fujiwara H., Ozaki A., Yoshimitsu M., Hamada H., Masamoto I., Matsushita K., Yasukawa M., Tei C. 2008; Allogeneic stem cell transplantation for refractory adult T-cell leukemia using a non-T-cell-depleted HLA-incompatible family donor graft, with reference to the grown-up child donor to parent recipient setting: report of a pilot study. Int J Hematol 87:319–326 [CrossRef]
   [Google Scholar]
6. Gaudray G., Gachon F., Basbous J., Biard-Piechaczyk M., Devaux C., Mesnard J. M. 2002; The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol 76:12813–12822 [CrossRef]
   [Google Scholar]
7. Harashima N., Kurihara K., Utsunomiya A., Tanosaki R., Hanabuchi S., Masuda M., Ohashi T., Fukui F., Hasegawa A. other authors 2004; Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res 64:391–399 [CrossRef]
   [Google Scholar]
8. Jiang S. B., Ojcius D. M., Persechini P. M., Young J. D. 1990; Resistance of cytolytic lymphocytes to perforin-mediated killing. Inhibition of perforin binding activity by surface membrane proteins. J Immunol 144:998–1003
   [Google Scholar]
9. Kuzushima K., Hayashi N., Kimura H., Tsurumi T. 2001; Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8⁺ T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay. Blood 98:1872–1881 [CrossRef]
   [Google Scholar]
10. Lehmann C., Zeis M., Schmitz N., Uharek L. 2000; Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells. Blood 96:594–600
    [Google Scholar]
11. Lemasson I., Lewis M. R., Polakowski N., Hivin P., Cavanagh M. H., Thébault S., Barbeau B., Nyborg J. K., Mesnard J. M. 2007; HTLV-1 bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J Virol 81:1543–1553 [CrossRef]
    [Google Scholar]
12. Muller C., Tschopp J. 1994; Resistance of CTL to perforin-mediated lysis. Evidence for a lymphocyte membrane protein interacting with perforin. J Immunol 153:2470–2478
    [Google Scholar]
13. Odeberg J., Browne H., Metkar S., Froelich C. J., Brandén L., Cosman D., Söderberg-Nauclér C. 2003; The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins. J Virol 77:4539–4545 [CrossRef]
    [Google Scholar]
14. Ohminami H., Yasukawa M., Fujita S. 2000; HLA class I-restricted lysis of leukemia cells by a CD8⁺ cytotoxic T-lymphocyte specific for WT1 peptide. Blood 95:286–293
    [Google Scholar]
15. Satou Y., Matsuoka M. 2007; Implication of the HTLV-I bZIP factor gene in the leukemogenesis of adult T-cell leukemia. Int J Hematol 86:107–112 [CrossRef]
    [Google Scholar]
16. Satou Y., Yasunaga J., Yoshida M., Matsuoka M. 2006; HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A 103:720–725 [CrossRef]
    [Google Scholar]
17. Suemori K., Fujiwara H., Ochi T., Azuma T., Yamanouchi J., Narumi H., Yakushijin Y., Hato T., Hasegawa H., Yasukawa M. 2008; Identification of an epitope derived from CML66, a novel tumor-associated antigen broadly expressed in human leukemia, recognized by HLA-A*2402-restricted cytotoxic T lymphocytes. Cancer Sci 99:1414–1419 [CrossRef]
    [Google Scholar]
18. Taylor G. P., Matsuoka M. 2005; Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 24:6047–6057 [CrossRef]
    [Google Scholar]
19. Utsunomiya A., Miyazaki Y., Takatsuka Y., Hanada S., Uozumi K., Yashiki S., Tara M., Kawano F., Saburi Y. other authors 2001; Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 27:15–20 [CrossRef]
    [Google Scholar]
20. Yasukawa M., Ohminami H., Yakushijin Y., Arai J., Hasegawa A., Ishida Y., Fujita S. 1999; Fas-independent cytotoxicity mediated by human CD4⁺ CTL directed against herpes simplex virus-infected cells. J Immunol 162:6100–6106
    [Google Scholar]